According to Alnylam Pharmaceuticals 's latest financial reports the company's current earnings are HK$4.28 Billion. In 2025 the company made an earning of HK$4.96 Billion, an increase over its 2024 earnings that were of -HK$1.85 Billion. The earnings displayed on this page is the company's Pretax Income.